The Infectious Diseases Society of America and its HIV Medicine Association strongly support the incoming Administration’s request for $400 billion to strengthen our pandemic response and safely reopen schools.
Plans to significantly accelerate COVID-19 vaccine rollout announced by the Department of Health and Human Services today represent an important step toward controlling the pandemic.
IDSA releases new recommendations on the use of baricitinib in hospitalized patients with COVID-19 and an updated literature review on hydroxychloroquine for the Treatment & Management of Patients with COVID-19
The HIV Medicine Association is pleased to announce the special appointment of Marwan Haddad, MD, MPH, as chair-elect. Dr. Haddad served on the HIVMA Board of Directors from October 2017 to October 2020 and is medical director of the Center for Key Populations for Community Health Center, Inc.
The current obstacles to swift and widespread COVID-19 vaccine access are impeding control of the pandemic amid soaring rates of infections, illnesses, hospitalizations and deaths and must be addressed effectively and immediately.
Thursday January 14th 5:00pm EST
Join Dr. Ron Devine, FIDSA and Dr. Prashant Malhotra, FIDSA as they discuss the changes and provide practical insight on how to use the revised codes and associated documentation using real-world ID specific clinical examples. Register Today
Anthony Fauci, M.D., FIDSA, director of the National Institute of Allergy and Infectious Diseases, kicked off this year’s premier virtual infectious diseases conference with an overview of the public health and scientific challenges of COVID-19 in the United States. Login to this year’s program now.